FAS Wealth Partners’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $308K | Sell |
3,228
-158
| -5% | -$15.2K | 0.02% | 293 |
|
|
2026
Q1 | $351K | Buy |
3,386
+702
| +26% | +$79.6K | 0.02% | 269 |
|
|
2025
Q4 | $271K | Buy |
+2,684
| New | +$291K | 0.02% | 297 |
|
|
2025
Q2 | – | Sell |
-1,421
| Closed | -$209K | – | 459 |
|
|
2025
Q1 | $209K | Buy |
1,421
+8
| +0.6% | +$1.22K | 0.02% | 286 |
|
|
2024
Q4 | $229K | Sell |
1,413
-2
| -0.1% | -$327 | 0.02% | 284 |
|
|
2024
Q3 | $231K | Sell |
1,415
-138
| -9% | -$20.4K | 0.02% | 283 |
|
|
2024
Q2 | $212K | Sell |
1,553
-1
| -0.1% | -$139 | 0.02% | 281 |
|
|
2024
Q1 | $238K | Sell |
1,554
-43
| -3% | -$6.42K | 0.02% | 273 |
|
|
2023
Q4 | $228K | Hold |
1,597
| – | – | 0.02% | 271 |
|
|
2023
Q3 | $209K | Sell |
1,597
-170
| -10% | -$25.8K | 0.02% | 266 |
|
|
2023
Q2 | $281K | Buy |
1,767
+35
| +2% | +$5.64K | 0.04% | 224 |
|
|
2023
Q1 | $274K | Buy |
1,732
+73
| +4% | +$10.9K | 0.03% | 248 |
|
|
2022
Q4 | $233K | Sell |
1,659
-613
| -27% | -$87K | 0.03% | 266 |
|
|
2022
Q3 | $292K | Sell |
2,272
-80
| -3% | -$11.5K | 0.03% | 229 |
|
|
2022
Q2 | $332K | Buy |
2,352
+11
| +0.5% | +$1.57K | 0.03% | 221 |
|
|
2022
Q1 | $325K | Buy |
2,341
+13
| +0.6% | +$1.99K | 0.03% | 225 |
|
|
2021
Q4 | $406K | Buy |
2,328
+11
| +0.5% | +$1.83K | 0.04% | 217 |
|
|
2021
Q3 | $384K | Buy |
2,317
+10
| +0.4% | +$1.72K | 0.04% | 208 |
|
|
2021
Q2 | $415K | Sell |
2,307
-73
| -3% | -$13.3K | 0.04% | 203 |
|
|
2021
Q1 | $459K | Sell |
2,380
-410
| -15% | -$78.9K | 0.05% | 183 |
|
|
2020
Q4 | $563K | Buy |
2,790
+9
| +0.3% | +$1.86K | 0.06% | 158 |
|
|
2020
Q3 | $585K | Sell |
2,781
-43
| -2% | -$9.58K | 0.08% | 147 |
|
|
2020
Q2 | $619K | Buy |
2,824
+9
| +0.3% | +$1.8K | 0.09% | 135 |
|
|
2020
Q1 | $488K | Buy |
2,815
+10
| +0.4% | +$1.65K | 0.09% | 134 |
|
|
2019
Q4 | $431K | Buy |
2,805
+12
| +0.4% | +$1.79K | 0.07% | 142 |
|
|
2019
Q3 | $424K | Sell |
2,793
-140
| -5% | -$22.1K | 0.08% | 140 |
|
|
2019
Q2 | $449K | Sell |
2,933
-149
| -5% | -$22.8K | 0.08% | 136 |
|
|
2019
Q1 | $495K | Buy |
3,082
+11
| +0.4% | +$1.71K | 0.1% | 127 |
|
|
2018
Q4 | $473K | Sell |
3,071
-540
| -15% | -$84.1K | 0.11% | 124 |
|
|
2018
Q3 | $543K | Buy |
3,611
+11
| +0.3% | +$1.56K | 0.12% | 109 |
|
|
2018
Q2 | $487K | Sell |
3,600
-248
| -6% | -$30.6K | 0.13% | 108 |
|
|
2018
Q1 | $512K | Sell |
3,848
-259
| -6% | -$34.8K | 0.15% | 107 |
|
|
2017
Q4 | $611K | Buy |
4,107
+12
| +0.3% | +$1.63K | 0.16% | 93 |
|
|
2017
Q3 | $540K | Buy |
4,095
+83
| +2% | +$11.2K | 0.15% | 96 |
|
|
2017
Q2 | $535K | Buy |
4,012
+12
| +0.3% | +$1.62K | 0.16% | 90 |
|
|
2017
Q1 | $539K | Sell |
4,000
-1,425
| -26% | -$185K | 0.17% | 87 |
|
|
2016
Q4 | $651K | Buy |
5,425
+169
| +3% | +$19.9K | 0.19% | 71 |
|
|
2016
Q3 | $658K | Buy |
5,256
+16
| +0.3% | +$2.1K | 0.22% | 63 |
|
|
2016
Q2 | $725K | Sell |
5,240
-587
| -10% | -$76.1K | 0.27% | 49 |
|
|
2016
Q1 | $735K | Buy |
5,827
+16
| +0.3% | +$2.03K | 0.38% | 30 |
|
|
2015
Q4 | $737K | Buy |
5,811
+17
| +0.3% | +$2.11K | 0.37% | 37 |
|
|
2015
Q3 | $669K | Buy |
5,794
+655
| +13% | +$73.5K | 0.39% | 34 |
|
|
2015
Q2 | $535K | Buy |
5,139
+137
| +3% | +$14.8K | 0.27% | 43 |
|
|
2015
Q1 | $552K | Buy |
5,002
+19
| +0.4% | +$2.06K | 0.28% | 37 |
|
|
2014
Q4 | $519K | Sell |
4,983
-297
| -6% | -$29.7K | 0.27% | 38 |
|
|
2014
Q3 | $507K | Buy |
5,280
+110
| +2% | +$9.95K | 0.29% | 32 |
|
|
2014
Q2 | $473K | Buy |
5,170
+7
| +0.1% | +$627 | 0.27% | 32 |
|
|
2014
Q1 | $454K | Buy |
5,163
+4
| +0.1% | +$351 | 0.31% | 30 |
|
|
2013
Q4 | $479K | Buy |
+5,159
| New | +$465K | 0.28% | 29 |
|
Other funds holding CLX
FAS Wealth Partners's CLX Position: Q2 2026 in Review
FAS Wealth Partners reduced its Clorox (CLX) stake by 4.7% in Q2 2026, selling an estimated $15.2K and leaving 3,228 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #293.
FAS Wealth Partners first reported a position in CLX in Q4 2013 and has held it in 49 quarters since. The position peaked at $737K in Q4 2015. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- FAS Wealth Partners held 3,228 shares of Clorox worth $308K as of Q2 2026.
- FAS Wealth Partners sold 158 Clorox shares in Q2 2026, an estimated $15.2K.
- Clorox made up 0.02% of FAS Wealth Partners's portfolio in Q2 2026, its #293 holding.
- FAS Wealth Partners first reported a position in Clorox in Q4 2013 and has held it in 49 quarters since.
- FAS Wealth Partners's Clorox position peaked at $737K in Q4 2015.
- 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.